IBA Acquires ORA Group to Expand Nuclear Medicine Capabilities

IBA Acquires Radcal Corporation

February 9, 2024

Medical Devices

Belgium-based IBA (Ion Beam Applications S.A.) has signed an agreement to acquire all assets of Radcal Corporation, a California-based leader in diagnostic X‑ray measurement and dosimetry. The acquisition strengthens IBA's Medical Imaging Quality Assurance offering and expands its presence in the US; Radcal generated approximately USD 6 million in revenue in 2023 and employs about 35 people.

One Medical Acquires Iora Health

September 1, 2021

Healthcare Services

One Medical (1Life Healthcare, Inc.) completed the acquisition of Iora Health, a value-based primary care provider focused on Medicare populations. The deal expands One Medical's reach into senior and Medicare markets (Iora served ~39,000 patients as of July 31, 2021) and was executed via issuance/reservation of approximately 56 million One Medical shares.

Novartis Acquires Mariana Oncology

May 2, 2024

Biotechnology

Novartis will acquire Mariana Oncology for $1 billion upfront and up to $750 million in milestone payments, bringing Mariana's peptide-based radiopharmaceutical pipeline and manufacturing capabilities into Novartis. The deal adds radioligand therapeutic discovery, isotope supply chain and manufacturing know-how to Novartis to accelerate development and commercialization of targeted cancer therapies.

Isoray Completes Merger with Viewpoint Molecular Targeting

February 6, 2023

Biotechnology

Isoray, Inc. completed an all-stock merger with Viewpoint Molecular Targeting, effective February 3, 2023, combining Isoray's brachytherapy expertise with Viewpoint's radiopharmaceutical and diagnostic pipeline. Under the deal each Viewpoint share converted into 3.1642 shares of Isoray (totaling 136,545,075 shares, ~49% of Isoray's outstanding shares); Viewpoint CEO Thijs Spoor was named CEO of the combined company and outgoing Isoray CEO Lori Woods became Chair.

Cardinal Health Acquires Integrated Oncology Network for $1.115B

September 20, 2024

Healthcare Services

Cardinal Health has entered into a definitive agreement to acquire Integrated Oncology Network (ION) for $1.115 billion in cash. The acquisition adds more than 50 community-based practice sites and 100+ providers to Cardinal's Navista oncology practice alliance and expands the company's specialty oncology capabilities and practice management offerings.

SRBA Group Acquires Majority Stake in Corporate Construction Inc.

November 20, 2024

Construction

SRBA Group, a Dutch provider of controlled environment facilities, has acquired a majority interest in Corporate Construction Inc., a Brookfield, Connecticut-based specialist in cleanrooms, laboratories, industrial manufacturing and medical facility construction. The cross-border transaction was facilitated by IRIS Corporate Finance (Netherlands) and Protegrity Advisors (USA).